Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02487797 · ClinicalTrials.gov registry record · Phase 4
Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,003
- Enrollment target
NCT02487797: Completed Phase 4 study, sponsored by Northwestern University.
NCT02487797 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 1,003 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02487797, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,003 participants
- Enrollment target
Study Summary
Oxytocin is a medication that is often used to strengthen contractions to overcome delayed labor progress. The primary aim of this study is to determine whether receiving a higher dose of oxytocin lowers the chance of needing a cesarean section when compared to a lower dose of oxytocin. Other aims include examining the relationship between dose of oxytocin regimen and length of labor, postpartum hemorrhage, intrauterine infection, umbilical cord gas, neonatal Apgar score \<5 at 5 minutes, and need for neonatal intensive care.
Primary Outcome
Number of participants delivered by cesarean section
Interventions
- DRUG Oxytocin
- OTHER Sodium Chloride 0.9%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,003 participants |
| Start Date | 2015-09-28 |
| Est. Completion | 2020-09-28 |
| Phase | Phase 4 |
What the finished NCT02487797 record still lists
NCT02487797 is an interventional study that assigns participants to a tested intervention. Its 1,003 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% higher).
The record links to 0 conditions, and to 2 interventions - of which Oxytocin is the first listed.
NCT02487797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02487797 about?
NCT02487797 is a clinical study titled "Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation". Oxytocin is a medication that is often used to strengthen contractions to overcome delayed labor progress. The primary aim of this study is to determine whether receiving a higher dose of oxytocin lowers the chance of needing a cesarean section when compared to a lower dose of oxytocin. Other aims i...
What is the current status of trial NCT02487797?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,003 participants. The study started on 2015-09-28. Estimated completion is 2020-09-28.
What interventions are being tested in trial NCT02487797?
The interventions under investigation include: Oxytocin (DRUG), Sodium Chloride 0.9% (OTHER).
Who is sponsoring clinical trial NCT02487797?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02487797's enrollment target sits among peer trials
1,003 66th of 2000 higher than 1,935 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI